当前位置:首页 - 行情中心 - 派林生物(000403) - 财务分析 - 现金流量表

派林生物

(000403)

  

流通市值:169.52亿  总市值:171.26亿
流通股本:9.41亿   总股本:9.50亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金968,008,291.47491,956,690.342,512,148,781.991,868,361,377.74
  收到的税费返还5,367,630.65--269,295.57
  收到其他与经营活动有关的现金13,061,201.6412,152,522.5236,844,984.2630,011,111.12
  经营活动现金流入小计986,437,123.76504,109,212.862,548,993,766.251,898,641,784.43
  购买商品、接受劳务支付的现金714,626,626.57353,664,632.061,259,197,685.51991,914,787.97
  支付给职工以及为职工支付的现金195,007,275.3123,640,586.12327,941,939.63246,458,476.77
  支付的各项税费112,024,27761,812,943.45252,748,782.7182,533,803.9
  支付其他与经营活动有关的现金157,442,842.6880,830,399.52387,314,952.14250,200,519.25
  经营活动现金流出小计1,179,101,021.55619,948,561.152,227,203,359.981,671,107,587.89
  经营活动产生的现金流量净额-192,663,897.79-115,839,348.29321,790,406.27227,534,196.54
二、投资活动产生的现金流量:
  收回投资收到的现金660,000,00040,000,0001,821,060,575.34940,000,000
  取得投资收益收到的现金13,099,369.044,260,00034,454,090.4922,685,477.13
  处置固定资产、无形资产和其他长期资产收回的现金净额95,791.1854,200111,279.06129,566.77
  收到的其他与投资活动有关的现金26,926,027.3913,315,068.4955,035,616.4241,572,602.73
  投资活动现金流入小计700,121,187.6157,629,268.491,910,661,561.311,004,387,646.63
  购建固定资产、无形资产和其他长期资产支付的现金178,057,408.0794,346,822.66520,711,316.73295,950,586.09
  投资支付的现金860,000,000510,000,0001,696,760,575.341,520,860,575.34
  支付其他与投资活动有关的现金--29,125,70029,125,700
  投资活动现金流出小计1,038,057,408.07604,346,822.662,246,597,592.071,845,936,861.43
  投资活动产生的现金流量净额-337,936,220.46-546,717,554.17-335,936,030.76-841,549,214.8
三、筹资活动产生的现金流量:
  吸收投资收到的现金--14,264,911.3114,224,911.31
  其中:子公司吸收少数股东投资收到的现金--40,000-
  取得借款收到的现金258,151,722.36120,293,204.46571,814,032.29352,083,000
  收到其他与筹资活动有关的现金---18,224.07
  筹资活动现金流入小计258,151,722.36120,293,204.46586,078,943.6366,326,135.38
  偿还债务支付的现金225,020,253.08107,144,129.34408,911,726.95265,574,349
  分配股利、利润或偿付利息支付的现金263,568,181.664,184,355.16264,625,755.13156,233,135.51
  支付其他与筹资活动有关的现金3,159,348.07845,499.256,286,176.155,169,203.53
  筹资活动现金流出小计491,747,782.81112,173,983.75679,823,658.23426,976,688.04
  筹资活动产生的现金流量净额-233,596,060.458,119,220.71-93,744,714.63-60,650,552.66
四、汇率变动对现金及现金等价物的影响-8,285.78-2,924.08-28,116.37-23,319.15
五、现金及现金等价物净增加额-764,204,464.48-654,440,605.83-107,918,455.49-674,688,890.07
  加:期初现金及现金等价物余额1,320,360,554.611,320,360,554.611,428,279,010.11,428,279,010.1
  期末现金及现金等价物余额556,156,090.13665,919,948.781,320,360,554.61753,590,120.03
补充资料:
  净利润235,916,844.55-745,042,150.36-
  资产减值准备1,224,723.08-1,253,652.18-
  固定资产和投资性房地产折旧53,503,913.82-105,003,413.52-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧53,503,913.82-104,974,933.68-
    投资性房地产折旧--28,479.84-
  无形资产摊销10,167,262.6-20,099,774.35-
  长期待摊费用摊销4,631,699.48-4,450,183.02-
  处置固定资产、无形资产和其他长期资产的损失-785,805.25-118,875.57-
  固定资产报废损失454,300.7-3,458,747.99-
  公允价值变动损失6,227,157.72--6,380,660.77-
  财务费用-18,086,692.72--40,372,453.5-
  投资损失-13,721,248.52--17,738,586.13-
  递延所得税-813,919.75-9,480,238.29-
  其中:递延所得税资产减少89,177.45-19,610,773.37-
    递延所得税负债增加-903,097.2--10,130,535.08-
  存货的减少-368,094,721.19--325,127,674.69-
  经营性应收项目的减少63,188,902.22--131,420,068.61-
  经营性应付项目的增加-168,372,435.6--47,764,795.54-
  现金的期末余额556,156,090.13-1,320,360,554.61-
  减:现金的期初余额1,320,360,554.61-1,428,279,010.1-
  现金及现金等价物的净增加额-764,204,464.48--107,918,455.49-
公告日期2025-08-222025-04-242025-04-242024-10-28
审计意见(境内)标准无保留意见
TOP↑